Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Equity Ratio (2016 - 2025)

Nephros (NEPH) has 16 years of Equity Ratio data on record, last reported at 0.76 in Q3 2025.

  • For Q3 2025, Equity Ratio fell 4.03% year-over-year to 0.76; the TTM value through Sep 2025 reached 0.76, down 4.03%, while the annual FY2024 figure was 0.77, 8.68% up from the prior year.
  • Equity Ratio reached 0.76 in Q3 2025 per NEPH's latest filing, down from 0.78 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.87 in Q1 2021 and bottomed at 0.7 in Q4 2023.
  • Average Equity Ratio over 5 years is 0.8, with a median of 0.81 recorded in 2022.
  • Peak YoY movement for Equity Ratio: rose 16.22% in 2021, then fell 14.31% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.84 in 2021, then decreased by 3.37% to 0.81 in 2022, then decreased by 12.73% to 0.7 in 2023, then rose by 8.68% to 0.77 in 2024, then dropped by 1.37% to 0.76 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.76 in Q3 2025, 0.78 in Q2 2025, and 0.79 in Q1 2025.